Verotoxin Antibodies

Santa Cruz Biotechnology delivers a wide array of Verotoxin monoclonal antibodies for the detection and analysis of verotoxins, potent toxins produced by certain strains of Escherichia coli. Verotoxin monoclonal antibodies excel in various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Verotoxins play a critical role in the pathogenesis of gastrointestinal diseases, particularly in cases of hemolytic uremic syndrome (HUS), where they can lead to severe complications. Understanding the mechanisms of verotoxin action and its interactions with host cells is essential for developing therapeutic strategies and preventive measures against infections. The study of verotoxins is crucial for advancing our knowledge of bacterial virulence and its impact on human health. Verotoxin monoclonal antibodies enable researchers to investigate cellular pathways and molecular mechanisms involved in bacterial toxicity. Verotoxin monoclonal antibodies support cutting-edge research that contributes to the development of improved diagnostic tools and therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies continue to support scientific advancement in understanding bacterial pathogenesis and developing innovative therapeutic approaches.